Hi Simons77,
dont want to be picky but, they (Glory) should get the homework straight before posting. Our company name is NEUREN not Neuron.
2nd, we all should not be blind-sided that one day a better therapy will come to market, thats the normal progression of things in the best case scenario. What is important to consider is timing and the lead time Acadia/NeurEn has in terms of setting up the relationships & infrastructure required.
Enjoy the ride with NEUREN.
Neuren Media and Analyst Coverage, page-876
-
- There are more pages in this discussion • 296 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.44 |
Change
-0.420(2.01%) |
Mkt cap ! $2.617B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $20.61 | $20.26 | $2.512M | 122.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 174 | $20.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.45 | 405 | 12 |
View Market Depth
| Last trade - 14.31pm 27/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |